Drug reference
insulin glargine-lixisenatide
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Endocrine (Insulins)
Mechanism of action
Lixisenatide: Incretin mimetic; analogue of human glucagonlike peptide-1 (GLP-1); acts as GLP-1 receptor agonist to augment glucose-dependent insulin secretion, Insulin glargine: Basal insulin analog; insulin lowers blood glucose by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose
Common side effects
- Upper respiratory tract infection
- Nasopharyngitis
- Headache
- Nausea
- Documented symptomatic hypoglycemia
- Severe symptomatic hypoglycemia
- Diarrhea
Related conditions
Frequently asked questions
What drug class is insulin glargine-lixisenatide?
insulin glargine-lixisenatide belongs to: Endocrine.
How does insulin glargine-lixisenatide work?
Lixisenatide: Incretin mimetic; analogue of human glucagonlike peptide-1 (GLP-1); acts as GLP-1 receptor agonist to augment glucose-dependent insulin secretion, Insulin glargine: Basal insulin analog; insulin lowers blood glucose by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose
What are the common side effects of insulin glargine-lixisenatide?
Upper respiratory tract infection, Nasopharyngitis, Headache, Nausea, Documented symptomatic hypoglycemia, Severe symptomatic hypoglycemia, Diarrhea
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.